These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8509134)

  • 1. Phospholipids coupled to a carrier induce IgG antibody that blocks tumour necrosis factor induction by toxic malaria antigens.
    Bate CA; Taverne J; Kwiatkowski D; Playfair JH
    Immunology; 1993 May; 79(1):138-45. PubMed ID: 8509134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.
    Bate CA; Taverne J; Bootsma HJ; Mason RC; Skalko N; Gregoriadis G; Playfair JH
    Immunology; 1992 May; 76(1):35-41. PubMed ID: 1628898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.
    Bate CA; Taverne J; Román E; Moreno C; Playfair JH
    Immunology; 1992 Jan; 75(1):129-35. PubMed ID: 1537589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.
    Bate CA; Taverne J; Davé A; Playfair JH
    Immunology; 1990 Jul; 70(3):315-20. PubMed ID: 2379940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-containing toxic malaria antigens induce hypoglycaemia.
    Taylor K; Bate CA; Carr RE; Butcher GA; Taverne J; Playfair JH
    Clin Exp Immunol; 1992 Oct; 90(1):1-5. PubMed ID: 1395089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.
    Bate CA; Taverne J; Playfair JH
    Infect Immun; 1992 May; 60(5):1894-901. PubMed ID: 1563780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malarial parasites induce TNF production by macrophages.
    Bate CA; Taverne J; Playfair JH
    Immunology; 1988 Jun; 64(2):227-31. PubMed ID: 3292408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the adaptive immune response following immunization in pregnant sows (Sus scrofa) kept in two different housing systems.
    Grün V; Schmucker S; Schalk C; Flauger B; Stefanski V
    J Anim Sci; 2014 Aug; 92(8):3388-97. PubMed ID: 24948651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.
    Bate CA; Taverne J; Playfair JH
    Immunology; 1989 Apr; 66(4):600-5. PubMed ID: 2654012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria: toxins, cytokines and disease.
    Jakobsen PH; Bate CA; Taverne J; Playfair JH
    Parasite Immunol; 1995 May; 17(5):223-31. PubMed ID: 7675508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of TNF in vitro as a model for the identification of toxic malaria antigens.
    Taverne J; Bate CA; Playfair JH
    Lymphokine Res; 1989; 8(3):317-22. PubMed ID: 2674557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation.
    Gore ER; Gower J; Kurali E; Sui JL; Bynum J; Ennulat D; Herzyk DJ
    Toxicology; 2004 Apr; 197(1):23-35. PubMed ID: 15003331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.
    Bate CA; Kwiatkowski D
    Infect Immun; 1994 Aug; 62(8):3086-91. PubMed ID: 8039876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine.
    Amlot PL; Hayes AE; Gray D; Gordon-Smith EC; Humphrey JH
    Clin Exp Immunol; 1986 Apr; 64(1):125-35. PubMed ID: 2426019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of in vitro responses to type II collagen by splenocytes from arthritic BALB/c mice is possibly caused by intrinsic CD25+ regulatory cells.
    Bäckström F; Dahlgren U
    Scand J Immunol; 2008 Apr; 67(4):362-9. PubMed ID: 18248529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-dependent antibody responses in the rat: forms and sources of keyhole limpet hemocyanin matter.
    Lebrec H; Hock MB; Sundsmo JS; Mytych DT; Chow H; Carlock LL; Joubert MK; Reindel J; Zhou L; Bussiere JL
    J Immunotoxicol; 2014; 11(3):213-21. PubMed ID: 23961896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive development of IgG4 subclass antibodies in the primary and secondary responses to keyhole limpet haemocyanin in man.
    Bird P; Calvert JE; Amlot PL
    Immunology; 1990 Mar; 69(3):355-60. PubMed ID: 2312160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of immunization with non-genotoxic PAH-KLH conjugates on the resistance of organisms exposed to benzo(a)pyrene.
    Cernohorská H; Klimešová S; Lepša L; Jinoch P; Milcová A; Schmuczerová J; Topinka J; Lábaj J
    Mutat Res; 2012 Feb; 742(1-2):2-10. PubMed ID: 22138421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.